Mutations in the c-KIT gene, along with BRAF mutations, in part, considered to be involved in the mechanism of development and progression of melanoma, have been identified in mucosal melanoma, which not only implicates BRAF, but also c-KIT, as a promising molecular target (42–44). The gene discussed is KIT; the disease is melanoma.